Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zidebactam multiple ascending dose in healthy volunteers
NCT02674347Phase 1Completed
- Sponsor
- Wockhardt
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of zidebactam (3 arms), sponsored by Wockhardt. Primary endpoints: Adverse Events at 14 days, 12-lead Electrocardiogram at 14 days and 1 more. Started Feb 2016; status: completed.
02
Drugs
zidebactam
Beyond the preview
Go deeper on NCT02674347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02674347.